Authors
Loading...
Network pharmacology identifies key targets in oral submucosal fibrosis, suggesting Astragalus membranaceus as a therapeutic option.
Zhang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: